Compare AMETEK, Inc. (AME) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AMETEK, Inc. vs McKesson Corporation — how do they compare? AMETEK, Inc. trades at $257.94 (market cap $58.76B), while McKesson Corporation trades at $883.98 (market cap $105.14B). The key difference: McKesson Corporation is the larger of the two by market cap, and AMETEK, Inc. pays the higher dividend (0.53%). Which is the better fit depends on your goals.
| AME | MCK | |
|---|---|---|
Market Cap | $58.76B | $105.14B |
Sector | Industrials | Health |
52-Week High | $256.30 | $995.69 |
52-Week Low | $179.28 | $659.01 |
Enterprise Value | $60.30B | $111.67B |
Dividend Yield | 0.53% | 0.42% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AME's stock trades at $257.9, up 1.99% today, reflecting strong momentum after recent earnings beats. The company reported record Q2 2026 results with EPS of $2.09, exceeding estimates, and raised full-year guidance. Valuation metrics like a P/E of 37.47 and P/S of 7.51 are elevated, but supported by robust profitability, including a 20.04% net income margin and 14.56% ROE. Technical indicators show a bullish trend, with the current price near resistance at $258.
The outlook remains positive, driven by consistent earnings growth and strong demand across business segments. Key risks include high valuation multiples and potential economic headwinds. With a consensus price target of $281.86 and no sell ratings from analysts, the stock offers upside potential, but investors should monitor execution against guidance and market volatility.
McKesson (MCK) trades at $889.01, up 1.04% today, with a bullish technical outlook and strong institutional support. Recent Q1 2027 earnings beat expectations, with EPS of $9.93 versus $9.56, driven by specialty drug growth and oncology performance. Revenue reached $359.05B in 2025, with net income of $3.30B, though margins remain thin. The company raised full-year guidance, reflecting operational momentum.
The stock offers upside to the consensus price target of $990.67, supported by 80% analyst buy ratings. Key risks include reliance on pharmaceutical distribution margins, regulatory pressures, and competitive threats. Earnings consistency and cost discipline are critical for sustaining valuation multiples amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AMETEK, Inc.
Ametek is a diversified industrial conglomerate with over $6 billion in sales. The firm operates through an electronic instruments group and an electromechanical group. EIG designs and manufactures differentiated and advanced instruments for the process, aerospace, power, and industrial end markets. EMG is a focused, niche supplier of highly engineered automation solutions, thermal management systems, specialty metals, and electrical interconnects, among other products. About half of the firm's sales are made in the United States. The firm's asset-light strategy in place for nearly two decades emphasizes growth through acquisitions, new product development through research and development, driving operational efficiencies, and global and market expansion.
Read more on AME →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
